Align Technology (ALGN) | Stock Overview & Key Data
Align Technology Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $737.45 on September 20, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Align Technology ALGN | 13.18B Large-cap | 0.61% | 8.04% | 35.44% | -9.24% | -6.24% | -20.12% | -23.95% | -39.86% |
| Intuitive Surgical ISRG | 184.62B Large-cap | -1.99% | 0.22% | 15.22% | -3.07% | 0.62% | 20.39% | 153.51% | 146.51% |
| Becton, Dickinson BDX | 48.64B Large-cap | -1.71% | 1.23% | -13.05% | -25.51% | -22.90% | -24.51% | -27.71% | -33.60% |
| Alcon ALC | 42.79B Large-cap | -2.21% | -0.49% | 5.03% | 3.99% | 4.31% | -5.38% | 21.82% | 45.30% |
| ResMed RMD | 37.32B Large-cap | 0.13% | 2.24% | 25.45% | 8.65% | 12.30% | 25.18% | 13.71% | 28.85% |
| West Pharmaceutical WST | 16.00B Large-cap | -0.87% | -1.47% | 15.80% | -34.56% | -32.86% | -31.43% | -26.28% | -10.31% |
Ownership & Short Interest
Align Technology Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Align Technology would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
In the last 52 weeks, Align Technology reached a high of $263.24 (on July 18, 2024) and a low of $141.74 (on April 8, 2025).
Curious about Align Technology's size and valuation? Its market capitalization stands at 13.18B. When it comes to valuation, the P/E ratio (trailing twelve months) is 32.99, and the forward P/E (looking ahead) is 17.72.
As for dividends, Align Technology isn't currently offering a significant yield, or that specific data isn't available right now.
When looking at Align Technology, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG184.62B Healthcare Medical Instruments & Supplies 20.39% 153.51% Becton, Dickinson
BDX48.64B Healthcare Medical Instruments & Supplies -24.51% -27.71% Alcon
ALC42.79B Healthcare Medical Instruments & Supplies -5.38% 21.82% ResMed
RMD37.32B Healthcare Medical Instruments & Supplies 25.18% 13.71% West Pharmaceutical
WST16.00B Healthcare Medical Instruments & Supplies -31.43% -26.28% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
To get a sense of Align Technology's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 10.84%, the Debt to Equity ratio from the most recent quarter is 3.12, and its Gross Profit Margin stands at 69.45%.
Looking at Align Technology's growth, its revenue over the trailing twelve months (TTM) was $4B. Compared to the same quarter last year (YoY), quarterly revenue grew by -1.80%, and quarterly earnings saw a YoY growth of -11.20%.
Wondering who owns Align Technology stock? Company insiders (like executives and directors) hold about 6.68% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 94.30%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.